Home

Anti-Aging

Navigation

Anti-Aging » Anti-Aging and Lifestyle » Sleep » Indiplon Immediate-Release Nda Filed With Fda

Neurocrine Biosciences Inc. submitted a New Drug Application to the Food and Drug Administration for indiplon immediate-release capsules, an experimental treatment for insomnia.

Original Article: Indiplon Immediate-Release Nda Filed With Fda

Continue Reading: 1 2 3 4 5

Email This Article

Post Your Comment

Print This Article

Peer Rating System: Would you recommend this article?
No I wouldn't 1 2 3 4 5 Yes I Would
4.50 out of 5, With 2 Votes

Category Articles

Eli Lilly Pays Monsanto $300 Million for Controversial Dairy Hor
Cholesterol Pill Taken by Thousands Causes Cancer
Extraordinary Creative and Psychic Powers of Animals
World Water Crisis Underlies World Food Crisis
Exercise and Limited TV Time Keeps Kids Trim
Hospital Deaths Go Public
Half of All Food Produced Worldwide is Wasted
FDA Allows Irradiation of Produce
Researchers Question Whether HPV Vaccine is Worth the Risk
Text-Messaging Injuries Caused by Distraction

Nav: [ 1 2 3 4 5 >> ]

Site Tree | Disclaimer
Link Index | Resources | More Resources

What is Anti-Aging, Anti-Ageing or Antiaging?

Home

Anti-Aging

Anti-Aging Information Partners

Anti-Aging Conferences

Anti-Aging Books

Anti-Aging Extras

Syndicate

Tools

No I wouldn't 1 2 3 4 5 Yes I Would

What is Anti-Aging, Anti-Ageing or Antiaging?

We are not affiliated with the American Academy for Anti-Aging Medicine (A4M)